Literature DB >> 24282114

Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure.

Charalambos Gustav Antoniades1, Wafa Khamri, Robin D Abeles, Leonie S Taams, Evangelos Triantafyllou, Lucia A Possamai, Christine Bernsmeier, Ragai R Mitry, Alistair O'Brien, Derek Gilroy, Robert Goldin, Michael Heneghan, Nigel Heaton, Wayel Jassem, William Bernal, Diego Vergani, Yun Ma, Alberto Quaglia, Julia Wendon, Mark Thursz.   

Abstract

UNLABELLED: Acetaminophen-induced acute liver failure (AALF) is characterized both by activation of innate immune responses and susceptibility to sepsis. Circulating monocytes and hepatic macrophages are central mediators of inflammatory responses and tissue repair processes during human AALF. Secretory leukocyte protease inhibitor (SLPI) modulates monocyte/macrophage function through inhibition of nuclear factor kappa B (NF-κB) signaling. The aims of this study were to establish the role of SLPI in AALF. Circulating levels of SLPI, monocyte cluster of differentiation 163 (CD163), human leukocyte antigen-DR (HLA-DR), and lipopolysaccharide (LPS)-stimulated levels of NF-κBp65, tumor necrosis factor alpha (TNF-α) and interleukin (IL)-6 were determined in patients with AALF, chronic liver disease, and healthy controls. Immunohistochemistry and multispectral imaging of AALF explant tissue determined the cellular sources of SLPI and hepatic macrophage phenotype. The phenotype and function of monocytes and macrophages was determined following culture with recombinant human (rh)-SLPI, liver homogenates, and plasma derived from AALF patients in the presence and absence of antihuman (α)SLPI. Hepatic and circulatory concentrations of SLPI were elevated in AALF and immunohistochemistry revealed SLPI expression in biliary epithelial cells and within hepatic macrophages (h-mψ) in areas of necrosis. H-mψ and circulating monocytes in AALF exhibited an anti-inflammatory phenotype and functional characteristics; typified by reductions in NF-κBp65, TNF-α, and IL-6 and preserved IL-10 secretion following LPS challenge. Culture of healthy monocytes with AALF liver homogenates, plasma, or rhSLPI induced monocytes with strikingly similar anti-inflammatory characteristics which were reversed by inhibiting the activity of SLPI.
CONCLUSION: SLPI is a pivotal mediator of anti-inflammatory responses in AALF through modulation of monocyte/macrophage function, which may account for the susceptibility to sepsis in AALF.
© 2014 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24282114     DOI: 10.1002/hep.26933

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  32 in total

Review 1.  Liver macrophages in tissue homeostasis and disease.

Authors:  Oliver Krenkel; Frank Tacke
Journal:  Nat Rev Immunol       Date:  2017-03-20       Impact factor: 53.106

2.  Understanding paracetamol-induced liver failure.

Authors:  Fin Stolze Larsen; Julia Wendon
Journal:  Intensive Care Med       Date:  2014-04-16       Impact factor: 17.440

3.  [Relationship between expression of peripheral blood HLA-DR, CD4+CD25+ regulatory T cells, IL-17 and IL-27 with liver damage in children with human cytomegalovrius infection].

Authors:  Li-Li Zhu; Ling Xu; Jun Wang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-07

4.  Donor biomarkers as predictors of organ use and recipient survival after neurologically deceased donor organ transplantation.

Authors:  Shengnan Li; Shu Wang; Raghavan Murugan; Ali Al-Khafaji; Daniel J Lebovitz; Michael Souter; Susan R N Stuart; John A Kellum
Journal:  J Crit Care       Date:  2018-08-18       Impact factor: 3.425

5.  CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.

Authors:  Luiz Eduardo Baggio Savio; Paola de Andrade Mello; Vanessa R Figliuolo; Thiago F de Avelar Almeida; Patrícia T Santana; Suellen D S Oliveira; Claudia L M Silva; Linda Feldbrügge; Eva Csizmadia; Richard D Minshall; Maria Serena Longhi; Yan Wu; Simon C Robson; Robson Coutinho-Silva
Journal:  J Hepatol       Date:  2017-05-26       Impact factor: 25.083

6.  Ferulic acid attenuated acetaminophen-induced hepatotoxicity though down-regulating the cytochrome P 2E1 and inhibiting toll-like receptor 4 signaling-mediated inflammation in mice.

Authors:  Junhui Yuan; Kuang Ge; Junhuan Mu; Jiang Rong; Li Zhang; Bin Wang; Jingyuan Wan; Gong Xia
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

Review 7.  Secretory leukocyte protease inhibitor promising protective roles in obesity-associated atherosclerosis.

Authors:  Qiao-Qing Zhong; Xiang Wang; Yun-Feng Li; Li-Jun Peng; Zhi-Sheng Jiang
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

Review 8.  Role of inflammation and infection in the pathogenesis of human acute liver failure: Clinical implications for monitoring and therapy.

Authors:  Mhairi C Donnelly; Peter C Hayes; Kenneth J Simpson
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

9.  Secretory leukocyte protease inhibitor is a proliferation and survival factor for pancreatic cancer cells.

Authors:  J Zuo; C Zhang; C Ren; D Pang; Y Li; X Xie; Z Tang; X Jiang
Journal:  Clin Transl Oncol       Date:  2014-10-16       Impact factor: 3.405

Review 10.  Inflammasome activation and function in liver disease.

Authors:  Gyongyi Szabo; Jan Petrasek
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-09       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.